tag:blogger.com,1999:blog-9551150.post2878632781361002173..comments2024-03-28T01:27:23.408-04:00Comments on Health Care Renewal: For a Few Dollars More: Academic Ideals Go Up in SmokeRoy M. Poses MDhttp://www.blogger.com/profile/00497209843184497847noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-9551150.post-32051884099591835982008-05-27T16:00:00.000-04:002008-05-27T16:00:00.000-04:00Alan Finder is the NYT reporter for this story. Th...Alan Finder is the NYT reporter for this story. The <A HREF="http://www.nytimes.com/2008/05/27/opinion/27tue2.html" REL="nofollow">NYT Editorial Board has weighed in as well today (May 27)</A>. Separately, the <A HREF="http://www.roanoke.com/editorials/wb/163242" REL="nofollow">Roanoke Times</A> has an insightful editorial as well.<BR/><BR/>Extensive background on and discussion of this situationAnonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-44366664140766585522008-05-25T11:58:00.000-04:002008-05-25T11:58:00.000-04:00The May 22, 2008, WSJ highlights an AP story about...The May 22, 2008, WSJ highlights an AP story about Merck ending a study on a new cholesterol drug due to the less than expected results. "This was done three weeks after US regulators refused to allow sales of the drug."<BR/><BR/>Steve Nissen of the Cleveland Clinic had this to say: "I am concerned whether the reason for terminating this trial is commercial or scientific."<BR/><BR/>While it is Anonymousnoreply@blogger.com